A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data Supplemental Figure 3

A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data Supplemental Figure 3

A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data Supplemental Figure 3

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cheema, Parneet, Cho, Byoung Chul, Freitas, Helano, Provencio, Mariano, Chen, Yuh Min, Kim, Sang-We, Wu, Yi-Long, Passaro, Antonio, Martin, Claudio, Tiseo, Marcello, Chang, Gee-Chen, Park, Keunchil, Solomon, Benjamin, Burghuber, Otto, Laskin, Janessa, Wang, Ziping, Lee, Sung Yong, Hu, Yanping, Vansteenkiste, Johan, Zhang, He-long, Hanrahan, Emer, Geldart, Thomas, Taylor, Rosemary, Servidio, Leslie, Li, Jingyi, de Marinis, Filippo
Format: Bild
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data Supplemental Figure 3
DOI:10.25402/fon.22439143